(Q40024241)

16 September 2017

title

Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer (English)

1 reference

Adaptive radiation therapy

16 September 2017

main subject

0 references

1 reference

9

0 references

author name string

Hiroshi Yokouchi

1

1 reference

16 September 2017

Koichi Yamazaki

2

1 reference

16 September 2017

Kenji Chamoto

3

1 reference

16 September 2017

Eiki Kikuchi

4

1 reference

16 September 2017

Naofumi Shinagawa

5

1 reference

16 September 2017

Satoshi Oizumi

6

1 reference

16 September 2017

Fumihiro Hommura

7

1 reference

16 September 2017

Takashi Nishimura

8

1 reference

16 September 2017

language of work or name

1 reference

14 January 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

99

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

361-367

1 reference

Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

Survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

Immune modulation by ionizing radiation and its implications for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

Combining radiotherapy and immunotherapy: a revived partnership

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

Introduction of soluble protein into the class I pathway of antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

Costimulation of CD8 T cell responses by OX40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00664.X

10.1111/J.1349-7006.2007.00664.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference